These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1171764)

  • 1. Cytosine arabinoside uptake by tumour cells in vitro.
    Mulder JH; Harrap KR
    Eur J Cancer (1965); 1975 May; 11(5):373-9. PubMed ID: 1171764
    [No Abstract]   [Full Text] [Related]  

  • 2. Transport and phosphorylation as factors in the antitumor action of cytosine arabinoside.
    Kessel D; Hall TC; Wodinsky I
    Science; 1967 Jun; 156(3779):1240-1. PubMed ID: 6025544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia.
    Kessel D; Shurin SB
    Biochim Biophys Acta; 1968 Sep; 163(2):179-87. PubMed ID: 5686275
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism and intracellular retention of 1-beta-D-arabinofuranosylcytosine as predictors of response of animal tumors.
    Rustum YM
    Cancer Res; 1978 Mar; 38(3):543-9. PubMed ID: 203383
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 5-fluorodeoxyuridine on cell viability and uptake of deoxycytidine and (3H)cytosine arabinoside in L5178Y cells.
    Chu MY; Hoovis ML; Fischer GA
    Biochem Pharmacol; 1976 Feb; 25(3):355-7. PubMed ID: 131557
    [No Abstract]   [Full Text] [Related]  

  • 6. THE REVERSAL OF CYTOSINE ARABINOSIDE ACTIVITY IN VIVO BY DEOXYCYTIDINE.
    EVANS JS; MENGEL GD
    Biochem Pharmacol; 1964 Jul; 13():989-94. PubMed ID: 14201141
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
    Takenaka T; Kimura K
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176
    [No Abstract]   [Full Text] [Related]  

  • 8. Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activity.
    Cory AH; Shibley IA; Chalovich JM; Cory JG
    J Biol Chem; 1993 Jan; 268(1):405-9. PubMed ID: 8380161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    EVANS JS; BOSTWICK L; MENGEL GD
    Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro studies using E. coli L-asparaginase on lymphatic cells of bovine leukemia and various transplantation tumors].
    Hirschmann WD; Seeber S; Warnecke P
    Klin Wochenschr; 1969 Nov; 47(22):1217-20. PubMed ID: 4909985
    [No Abstract]   [Full Text] [Related]  

  • 11. Computer simulation of leukemia therapy: combined pharmacokinetics, intracellular enzyme kinetics, and cell kinetics of the treatment of L1210 leukemia by cytosine arabinoside.
    Lincoln T; Morrison P; Aroesty J; Carter G
    Cancer Treat Rep; 1976 Dec; 60(12):1723-39. PubMed ID: 1026330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of deaminated monophosphate nucleotide in extracellular sites after giving arabinofuranosylcytosine or deoxycytidine to mice.
    Chou TC; Hutchison DJ; Schmid FA; Philips FS
    Ann N Y Acad Sci; 1975 Aug; 255():287-91. PubMed ID: 1059362
    [No Abstract]   [Full Text] [Related]  

  • 13. Deamination rates of 1-beta-D-arabinofuranosylcytosine, deoxycytidine and 5-methyl-2'-deoxycytidine in seven hematopoietic cell lines.
    Jekunen A
    Med Biol; 1987; 65(4):203-8. PubMed ID: 3437781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labelling of the thymidine and deoxycytidine bases of DNA by [2-14C]deoxycytidine in cultured L1210 cells.
    Karle JM; Hoerauf RM; Cysyk RL
    Cancer Lett; 1983 Jun; 19(2):147-57. PubMed ID: 6883305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S; Lehman C; Cadman E
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract]   [Full Text] [Related]  

  • 16. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation.
    Durham JP; Ives DH
    Mol Pharmacol; 1969 Jul; 5(4):358-75. PubMed ID: 4308509
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical and cellular pharmacology of cytosine arabinoside.
    Kufe DW; Spriggs DR
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):34-48. PubMed ID: 3925560
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma half-life of cytosine arabinoside in patients with leukaemia--the effect of uridine.
    Baguley BC; Falkenhaug EM
    Eur J Cancer (1965); 1975 Jan; 11(1):43-9. PubMed ID: 1055682
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimation of sensitivity of human tumors to cytostatics in vitro. I.
    Andrysek O; Jandová A; Motycka K; Slavík K
    Neoplasma; 1968; 15(1):59-69. PubMed ID: 5650630
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes.
    Mayhew E; Rustum YM; Szoka F; Papahadjopoulos D
    Cancer Treat Rep; 1979; 63(11-12):1923-8. PubMed ID: 526925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.